Related Experiment Video
Updated: May 5, 2026

Assays for the Degradation of Misfolded Proteins in Cells
Published on: August 28, 2016
D-polyglutamine amyloid recruits L-polyglutamine monomers and kills cells
Karunakar Kar1, Irene Arduini1, Kenneth W Drombosky1
1Department of Structural Biology, University of Pittsburgh School of Medicine, Biomedical Science Tower 3, 3501 Fifth Avenue, Pittsburgh, PA 15260, USA; Pittsburgh Institute for Neurodegenerative Diseases, University of Pittsburgh School of Medicine, Biomedical Science Tower 3, 3501 Fifth Avenue, Pittsburgh, PA 15260, USA.
Abstract:
Polyglutamine (polyQ) amyloid fibrils are observed in disease tissue and have been implicated as toxic agents responsible for neurodegeneration in expanded CAG repeat diseases such as Huntington's disease. Despite intensive efforts, the mechanism of amyloid toxicity remains unknown. As a novel approach to probing polyQ toxicity, we investigate here how some cellular and physical properties of polyQ amyloid vary with the chirality of the glutamine residues in the polyQ. We challenged PC12 cells with small amyloid fibrils composed of either L- or D-polyQ peptides and found that D-fibrils are as cytotoxic as L-fibrils. We also found using fluorescence microscopy that both aggregates effectively seed the aggregation of cell-produced L-polyQ proteins, suggesting a surprising lack of stereochemical restriction in seeded elongation of polyQ amyloid. To investigate this effect further, we studied chemically synthesized D- and L-polyQ in vitro. We found that, as expected, D-polyQ monomers are not recognized by proteins that recognize L-polyQ monomers. However, amyloid fibrils prepared from D-polyQ peptides can efficiently seed the aggregation of L-polyQ monomers in vitro, and vice versa. This result is consistent with our cell results on polyQ recruitment but is inconsistent with previous literature reports on the chiral specificity of amyloid seeding. This chiral cross-seeding can be rationalized by a model for seeded elongation featuring a "rippled β-sheet" interface between seed fibril and docked monomers of opposite chirality. The lack of chiral discrimination in polyQ amyloid cytotoxicity is consistent with several toxicity mechanisms, including recruitment of cellular polyQ proteins.
Insights
Polyglutamine (polyQ) amyloid fibrils show similar toxicity regardless of chirality. Unexpectedly, D-polyQ fibrils can seed L-polyQ aggregation, challenging previous models of amyloid stereospecificity.
Area of Science:
- Neurodegenerative diseases
- Protein misfolding and aggregation
- Biochemistry and molecular biology
Background:
- Polyglutamine (polyQ) amyloid fibrils are implicated in neurodegeneration in diseases like Huntington's disease.
- The precise mechanism of polyQ amyloid toxicity remains largely unknown.
- Understanding polyQ properties, including chirality, may offer novel insights into toxicity.
Purpose of the Study:
- To investigate the cellular and physical properties of polyQ amyloid fibrils based on glutamine residue chirality.
- To explore the role of chirality in polyQ amyloid cytotoxicity and seeded aggregation.
- To examine the stereochemical specificity of polyQ amyloid seeding in vitro and in cells.
Main Methods:
- Challenging PC12 cells with L- and D-polyQ amyloid fibrils.
- Utilizing fluorescence microscopy to observe seeded aggregation of cellular L-polyQ.
- In vitro studies with chemically synthesized D- and L-polyQ peptides and fibrils.
Main Results:
- D-polyQ fibrils exhibited cytotoxicity comparable to L-polyQ fibrils in PC12 cells.
- Both L- and D-polyQ fibrils effectively seeded the aggregation of cellular L-polyQ proteins.
- In vitro, D-polyQ fibrils efficiently seeded L-polyQ monomer aggregation, and vice versa, indicating chiral cross-seeding.
Conclusions:
- PolyQ amyloid cytotoxicity does not appear to be stereochemically restricted.
- Chiral cross-seeding of polyQ amyloid aggregation occurs, challenging previous assumptions of chiral specificity.
- The findings support toxicity mechanisms involving the recruitment of cellular polyQ proteins.
Related Concept Videos
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Abnormal Proliferation

